Received Sep 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
use of Flublok influenza vaccine off-label as dosing twice yearly, with no reported adverse event; Initial information received on 17-Sep-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age and unknown gender patient who took Influenza Trivalent Recombinant Vaccine [Flublok TIV] twice yearly, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, an unknown age and unknown gender patient who received an unknown dose of suspect Influenza Trivalent Recombinant Vaccine (lot number, strength and expiry date-unknown) via intramuscular route in unknown administration site for Influenza vaccination (Influenza immunisation) twice yearly, with no reported adverse event (off label use) (latency-1 day). Information on the batch number was requested corresponding to the one at time of event occurrence. Action taken was not applicable.